| 1 | DNA deamination (GO:0045006) | 6.28922810 |
| 2 | leukotriene biosynthetic process (GO:0019370) | 5.96979979 |
| 3 | behavioral response to nicotine (GO:0035095) | 5.58421320 |
| 4 | growth hormone secretion (GO:0030252) | 5.30322035 |
| 5 | protein K11-linked deubiquitination (GO:0035871) | 5.23961321 |
| 6 | organelle membrane fusion (GO:0090174) | 5.23362623 |
| 7 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 5.19588848 |
| 8 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 5.12088596 |
| 9 | cysteine metabolic process (GO:0006534) | 5.08009908 |
| 10 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 5.05010929 |
| 11 | positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568) | 4.87898990 |
| 12 | regulation of RIG-I signaling pathway (GO:0039535) | 4.70678370 |
| 13 | cytidine deamination (GO:0009972) | 4.67435815 |
| 14 | cytidine metabolic process (GO:0046087) | 4.67435815 |
| 15 | cytidine catabolic process (GO:0006216) | 4.67435815 |
| 16 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.54345959 |
| 17 | positive regulation of growth hormone secretion (GO:0060124) | 4.24386312 |
| 18 | sulfation (GO:0051923) | 4.12201916 |
| 19 | positive regulation of prostaglandin secretion (GO:0032308) | 4.11554046 |
| 20 | leukotriene metabolic process (GO:0006691) | 4.11446746 |
| 21 | mitochondrial calcium ion transport (GO:0006851) | 4.09644875 |
| 22 | protein polyglutamylation (GO:0018095) | 4.06997462 |
| 23 | transmission of nerve impulse (GO:0019226) | 4.02352926 |
| 24 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.98345706 |
| 25 | piRNA metabolic process (GO:0034587) | 3.96116865 |
| 26 | iron-sulfur cluster assembly (GO:0016226) | 3.81505344 |
| 27 | metallo-sulfur cluster assembly (GO:0031163) | 3.81505344 |
| 28 | neuronal action potential (GO:0019228) | 3.80371276 |
| 29 | NIK/NF-kappaB signaling (GO:0038061) | 3.75616096 |
| 30 | gamma-aminobutyric acid transport (GO:0015812) | 3.75223882 |
| 31 | negative regulation of mast cell activation (GO:0033004) | 3.70457862 |
| 32 | activated T cell proliferation (GO:0050798) | 3.68951972 |
| 33 | axoneme assembly (GO:0035082) | 3.67862695 |
| 34 | autophagic vacuole fusion (GO:0000046) | 3.62748015 |
| 35 | negative regulation of telomere maintenance (GO:0032205) | 3.54829537 |
| 36 | estrogen biosynthetic process (GO:0006703) | 3.53640461 |
| 37 | sulfate transmembrane transport (GO:1902358) | 3.50512606 |
| 38 | protein K48-linked deubiquitination (GO:0071108) | 3.45800386 |
| 39 | negative T cell selection (GO:0043383) | 3.43688412 |
| 40 | determination of adult lifespan (GO:0008340) | 3.41847290 |
| 41 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 3.37027143 |
| 42 | synaptic transmission, cholinergic (GO:0007271) | 3.33705819 |
| 43 | positive regulation of action potential (GO:0045760) | 3.33344891 |
| 44 | regulation of insulin-like growth factor receptor signaling pathway (GO:0043567) | 3.31777169 |
| 45 | regulation of prostaglandin secretion (GO:0032306) | 3.30380235 |
| 46 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.29779731 |
| 47 | fatty acid derivative biosynthetic process (GO:1901570) | 3.27158304 |
| 48 | icosanoid biosynthetic process (GO:0046456) | 3.27158304 |
| 49 | glycerophospholipid catabolic process (GO:0046475) | 3.21639115 |
| 50 | retinal cone cell development (GO:0046549) | 3.21636981 |
| 51 | negative regulation of oxidoreductase activity (GO:0051354) | 3.20327656 |
| 52 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.15851456 |
| 53 | GDP-mannose metabolic process (GO:0019673) | 3.11851398 |
| 54 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.08789517 |
| 55 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.06682170 |
| 56 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.04832762 |
| 57 | positive thymic T cell selection (GO:0045059) | 3.02196695 |
| 58 | negative thymic T cell selection (GO:0045060) | 3.00500288 |
| 59 | adaptation of signaling pathway (GO:0023058) | 3.00146976 |
| 60 | unsaturated fatty acid biosynthetic process (GO:0006636) | 2.99050331 |
| 61 | regulation of action potential (GO:0098900) | 2.98889529 |
| 62 | DNA methylation involved in gamete generation (GO:0043046) | 2.96541977 |
| 63 | sulfate transport (GO:0008272) | 2.95960848 |
| 64 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.95261780 |
| 65 | killing of cells of other organism (GO:0031640) | 2.90806791 |
| 66 | disruption of cells of other organism (GO:0044364) | 2.90806791 |
| 67 | L-fucose metabolic process (GO:0042354) | 2.85052630 |
| 68 | L-fucose catabolic process (GO:0042355) | 2.85052630 |
| 69 | fucose catabolic process (GO:0019317) | 2.85052630 |
| 70 | negative regulation of monooxygenase activity (GO:0032769) | 2.83131178 |
| 71 | positive T cell selection (GO:0043368) | 2.82028594 |
| 72 | positive regulation of fatty acid transport (GO:2000193) | 2.80731380 |
| 73 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.79276484 |
| 74 | regulation of protein polyubiquitination (GO:1902914) | 2.78868162 |
| 75 | neuron fate determination (GO:0048664) | 2.78649577 |
| 76 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.76779384 |
| 77 | activation of adenylate cyclase activity (GO:0007190) | 2.75474439 |
| 78 | dosage compensation (GO:0007549) | 2.74391087 |
| 79 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.73879332 |
| 80 | glutathione metabolic process (GO:0006749) | 2.73313566 |
| 81 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.72475315 |
| 82 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.72475315 |
| 83 | NADH dehydrogenase complex assembly (GO:0010257) | 2.72475315 |
| 84 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.72118887 |
| 85 | response to UV-C (GO:0010225) | 2.71969264 |
| 86 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.70342811 |
| 87 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.70318359 |
| 88 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.69970670 |
| 89 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.69970670 |
| 90 | modulation by symbiont of host immune response (GO:0052553) | 2.69970670 |
| 91 | positive regulation by symbiont of host defense response (GO:0052509) | 2.69970670 |
| 92 | modulation by symbiont of host defense response (GO:0052031) | 2.69970670 |
| 93 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.69970670 |
| 94 | regulation of ruffle assembly (GO:1900027) | 2.66263479 |
| 95 | response to interferon-beta (GO:0035456) | 2.63858720 |
| 96 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.63060012 |
| 97 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.63060012 |
| 98 | natural killer cell differentiation (GO:0001779) | 2.62965455 |
| 99 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.62513389 |
| 100 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.62027811 |
DUX4L9 
